Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT06083753 · COMPLETED
Trial details
- NCT number
- NCT06083753
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-06
- Primary completion
- 2025-07-14
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.